Siga Technologies
Presence
MacAndrews & Forbes has 4 subsidiaries including Savi, Siga Technologies and Vericast.
They are in:
- Communication & Sales40%
- Holding20%
- Other40%
Executives
View the org chart displaying its 18 main executives
Most searched biographies at Siga Technologies
Popular executive movements at Siga Technologies
- Larry Miller has joined the company as General Counsel (posted on March 25 2024).
- Nguyen Diem has joined the company as Chief Executive Officer and Director (posted on January 23 2024).
- Jay Varma, who was Director, is promoted to Director, Executive Vice President and Chief Medical Officer (posted on September 6 2023).
Popular executive movements at MacAndrews & Forbes
- Julian Nemirovsky, Senior Vice President, Capital Markets, has left the company (posted on December 27 2023).
Create your alert
to follow the executive moves at Siga Technologies.
Biotechnology
MacAndrews & Forbes has 2,275 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (posted on April 16 2024).
Popular contacts in Biotechnology
News
Press releases by Siga Technologies
- SIGA Technologies to Host Business Update Call on August 4th, 2022 Following Release of Second Quarter 2022 Financial Results | SIGA
- SIGA Announces Oncology Collaboration with KaliVir Immunotherapeutics | SIGA
- SIGA Announces Approximately $28 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat) | SIGA
- SIGA Technologies Receives Approval from UK for Tecovirimat | SIGA
- SIGA Announces $13 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat) | SIGA
- SIGA to Participate in Alliance Global Partners’ Monkeypox Panel on Thursday, June 23rd 2022 | SIGA
- Press Releases | SIGA
- Press Releases | SIGA
- SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX® (tecovirimat) | SIGA
- New Contract Awarded by U.S. Department of Defense for the Procurement of up to Approximately $7.5 Million of Oral TPOXX® | SIGA
- View more press releases Close
Social media about Siga Technologies
- Siga Technologies on Wikipedia, Google News & Yahoo Finance
- Siga Technologies on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Jaymie Durnan 
Call Siga Technologies at +1 212...
